BRAF and neoplasm: BRAF PTEN PREX2 and BRAF P53 PREX2 were sensitive to AZD6244, with response resulting in substantial tumor regression in both models, albeit with more prolonged sensitivity in BRAF PTEN PREX2 (Fig. 2A and S2B; Supplementary Fig. S4B).